Meco, Daniela <br/><br/>
Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Dec 2012 
 - 811-22 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-012-1973-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Camptothecin--analogs & derivatives<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cerebellar Neoplasms--drug therapy<br/>Child<br/>Comet Assay<br/>DNA Damage--drug effects<br/>Drug Synergism<br/>Humans<br/>Irinotecan<br/>Medulloblastoma--drug therapy<br/>Mice<br/>Mice, Nude<br/>Neuroblastoma--drug therapy<br/>Neuroectodermal Tumors, Primitive--drug therapy<br/>Platinum Compounds--administration & dosage<br/>Xenograft Model Antitumor Assays